Education
About Us
Working with TipRanks
Follow Us
HeartFlow, Inc. (HTFL)
NASDAQ:HTFL
HTFL Stock Chart & Stats
$32.07
--
Market closed
$32.07
--
Day’s Range― - ―
52-Week Range$25.38 - $41.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)739.63K
Market Cap
$2.71B
Enterprise Value$2.44B
Total Cash (Recent Filing)$291.17M
Total Debt (Recent Filing)$21.79M
Price to Earnings (P/E)―
Beta2.58
Next Earnings
Feb 12, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding85,158,720
10 Day Avg. Volume909,458
30 Day Avg. Volume739,634
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)-2.11
Price to Sales (P/S)14.41
P/FCF Ratio-24.71
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue7.06
Enterprise Value/Gross Profit9.29
Enterprise Value/Ebitda-17.65
Forecast
1Y Price Target
$38.60Price Target Upside20.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-1.94
Revenue Forecast (FY)$165.86M
Bulls Say, Bears Say
Bulls Say
Commercial TractionRevenue beats and an expanding sales funnel point to improving commercial execution that may translate into steady account additions and higher utilization per site.
Product AdoptionEarly clinical feedback indicates PCI Navigator has strong initial reception among interventional cardiologists, which could strengthen HeartFlow's role in coronary procedure workflows and drive device-led referrals.
Technology AdoptionAnalysts expect wider adoption of coronary CT angiography to increase demand for HeartFlow's FFRct software, supporting unit growth as more imaging centers integrate the technology.
Bears Say
Medicare Payment RateFinalized Medicare payment for FFRct in 2026 is lower than prior levels at about $877, which reduces revenue per test and pressures per-case economics.
Pricing PressureImplied U.S. average selling price came in slightly below expectations, posing a risk to margins if volume gains do not fully offset price pressure.
Reimbursement VolatilityMovement in APC components has created variability in reimbursement levels, increasing uncertainty for future revenue forecasts and payer negotiations.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $25.38 and its highest was $41.22 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
HeartFlow, Inc.’s market cap is $2.71B.
When is HeartFlow, Inc.’s upcoming earnings report date?
HeartFlow, Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 28 days.
How were HeartFlow, Inc.’s earnings last quarter?
HeartFlow, Inc. released its earnings results on Nov 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.242 by -$0.028.
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate is -0.17.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 85,158,720 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
HeartFlow, Inc. reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.242. Following the earnings report the stock price went down -13.43%.
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HeartFlow, Inc. Stock Smart Score
Company Description
HeartFlow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Earnings Call
Q3 2025
0:00 / 0:00
HTFL Stock 12 Month Forecast
Average Price Target
$38.60
▲(20.36% Upside)
Technical Analysis
Ownership Overview
35.45% Insiders
9.70% Mutual Funds
29.81% Other Institutional Investors
23.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---